Scienture Holdings, Inc. cotiza a 3.91 USD y tiene una capitalización bursátil de $6M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for th…
| Periodo | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|
| Real | $-1.75 | $-2.00 | $-3.17 |
| Estimado | $-2.25 | $-5.50 | $-7.00 |
| Sorpresa | +22.2% | +63.6% | +54.7% |
| Métrica | SCNX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 76.8% | 57.0% | +19.8% |
| Operating Margin | -9867.9% | -38.6% | -9829.3% |
| Net Margin | -9618.0% | -33.6% | -9584.5% |
| FCF Margin | — | -13.9% | — |
| ROE | -59.2% | -40.4% | -18.8% |
| ROA | -49.3% | -32.0% | -17.3% |
| Current Ratio | 2.89 | 2.84 | +0.05 |
| Debt / Equity | — | 0.28 | — |